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                Dean’s Newsletter
School of Medicine
Research Focuses on 
Building New Bone
From the earliest days of my career in orthopaedic surgery and chemical 
engineering, I have been 
fascinated with the prospect of 
regrowing bone and connective 
tissue to help patients regain 
mobility. It is now my privilege 
to be leading teams of scientists 
not only in my own lab but 
throughout the UConn Health 
Center who are pursuing 
promising research in this area.  
 This includes Dr. David 
Rowe who has devoted most 
of his career to the study of 
osteogenesis imperfecta and is 
now pioneering new approaches 
for bone and tissue regeneration 
through the use of adult and 
embryonic stem cells. These 
efforts have received robust 
extramural support and have 
fostered collaborative efforts with 
scientific colleagues throughout 
the University of Connecticut – 
the top public university in New 
England. 
 Like you, I am confident that 
teams on campuses across the 
country will continue to make 
breakthroughs to improve care 
for generations to come. I hope 
you will enjoy learning more 
Dean’s Message
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organized and focused. “And I think it broadens their horizons, 
too. They’re talking about a lot more possibilities in terms of what 
they would like to do, as opposed to having a narrow focus.” 
 One pipeline program is the Aetna HPPI Saturday Academy, 
which follows students throughout their high school careers. 
They meet at UConn’s Hartford campus on Saturdays during the 
academic year and full time for six weeks during the summer, with 
a focus on advancement in math, science, and language arts, and 
standardized testing preparation. 
 All participants in the Aetna HPPI are mentored by medical, 
dental, and graduate students, and faculty at the Health Center. 
The pipeline also offers a broad range of programs for middle 
school, high school, and college students – from a high school-
level research apprentice program to a clinical summer research 
fellowship program for undergraduate students. 
 Information on all HCOP enrichment programs is available at 
http://hcop.uchc.edu. n
The UConn Health Center’s Health Career Opportunity Programs (HCOP) open doors to careers in medicine, dental medicine, biomedical research, and other health professions for students 
who are disadvantaged or from populations underrepresented in 
such fields. 
 With funding from public and private sources including the 
Aetna Foundation, HCOP director Marja M. Hurley, M.D., oversees 
a number of programs collectively known as the Aetna Health 
Professions Partnership Initiative (HPPI) pipeline. This year, 23 of 
UConn’s 117 medical and dental school graduates were considered 
underrepresented – including minority students and those who  
are economically or educationally disadvantaged. Fifteen of those  
23, more than 65 percent, participated in at least one pipeline  
program. “It’s been an increasing trend over really the last 10  
years,” Hurley says. 
 HCOP associate director Granville Wrensford, Ph.D., C.R.A., 
says he’s found the students in the program to be more motivated, 
(from left) Megan Almonte, 
Travis Townsend, Patrick 
Richards, Marja M. Hurley, 
M.D., Kierra Odom,  
Lamont Freeman, and  
Lilliana Garcia.
about this and some of the 
other exciting endeavors at the 
UConn School of Medicine. 
 My best wishes to all as we 
begin a new academic year. 
 
Sincerely, 
 
 
 
 
Cato T. Laurencin, M.D., Ph.D. 
Vice President for Health Affairs 
Dean, UConn School of Medicine 
laurencin@uchc.edu 
 
Diversifying the Health  
Professions Pipeline
Modern genetic testing can predict your risk of contracting particular diseases based on predispositions discovered in your DNA. Jim Rusling, Ph.D., professor of chemistry at UConn and professor of cell biology at the UConn Health Center, is hoping similar 
biotechnology could detect disease even before any symptoms arise.   
 Rusling and his colleagues have been developing techniques to detect biomarker proteins 
– the physiological traits that indicate that a person has a specific disease – for prostate and 
oral cancer. Because these biomarkers are often present in the blood in a disease’s early stages, 
they can be used for early detection and prevention. 
 In the journal Analytical Chemistry, Rusling describes a system he and his team developed 
to detect with record sensitivity the bloodstream levels of a protein associated with several 
types of oral cancer. The protein, called interleukin-6, is normally present in very low levels 
in the bloodstream – so low that previous biomarker sensors might not be able to detect it. 
This and other biomarkers are signaling molecules, which can instruct cancerous cells to 
grow faster. Their levels can increase even before tumors begin to form, enabling early 
detection.  
 Currently, blood samples and antibodies need to be specially prepared and 
fed manually into the group’s testing setup. Rusling envisions that in clinics, an 
automated tester about the size of a cell phone could be developed to accept a 
sample of a person’s blood, analyze the sample, and read out the results. Such 
testers could make early detection much easier, he says, which could go a long way 
toward saving lives.  
 “There’s not going to be one cure for cancer, because cancer is thousands of 
diseases,” he says. “The best thing for patients is early detection. Biomarker proteins 
could become the standard of early detection and treatment monitoring in the future.” n
New Biomarker Technique Could  
Provide Early Detection for Oral Cancers
Mobility is a critical component of independence and 
quality of life for older persons. 
Research by Leslie Wolfson, 
M.D., and his team has shown 
for the first time that certain 
changes in the brain’s white 
matter are highly predictive of 
the development of disability 
in older adults. The results of 
the study are published in the 
Journal of the American  
Geriatrics Society. 
 Changes involving brain 
white matter are seen in many 
MRI brain scans of older adults. 
“They are so common that 
until recently it was assumed 
that they don’t matter and 
may represent normal aging,” 
explains Wolfson, professor 
and chair of the Department of 
Neurology. “But our research 
found that these brain changes 
are a good indicator of 
problems in older adults such  
as difficulty walking, thinking, 
and remaining continent.”  
 Wolfson believes that 
interventions such as aggressive 
treatment of elevated blood 
pressure may help prevent or 
slow these declines, 
allowing older 
adults to remain 
independent, 
vigorous, 
and healthy 
longer. n
Can Changes in  
the Brain Predict  
Disability in  
Older Adults?
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Jim Rusling, Ph.D., left, with graduate students 
Ruchika Malhotra and Bhaskara Chikkaveeraiah, 
developed a system to better detect interleukin-6.
Cell-Based Therapy  
Focuses on Building New Bone
David Rowe, M.D., is confident that medical science will one day enable patients to regrow bone and other tissues lost to disease, trauma, or aging. Rowe, director of the UConn 
School of Dental Medicine’s Center for Regenerative Medicine and 
Skeletal Development, is quick to note that this breakthrough, 
like others over the centuries, will be achieved only through 
rigorous, persistent research. 
 “It’s a very difficult challenge,” Rowe says. “A lot of work 
needs to be done before this becomes a reality. But we have the 
people, the tools, the resources, and the commitment to move  
the research forward.” 
 The research Rowe and his colleagues are engaged in 
focuses on how to use embryonic and adult stem cells to 
regenerate bone and other tissues in the body. The team has 
received funding for its work from the Connecticut Stem Cell 
Research Program, the National Institutes of Health, and the 
Department of Defense. 
 Rowe himself was recently honored as the recipient of 
the 2010 UConn Health Center Board of Directors Faculty 
Recognition Award. The award recognizes Rowe’s outstanding 
contributions to research, teaching, and mentoring. 
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David Rowe, M.D. reviews research 
data with Xiaonan Xin.  Li Chen works 
in the background. 
Treating Disease and Injury
O steogenesis imperfecta is Rowe’s main research interest. Commonly known as brittle bone disease, OI is a genetic disease that causes bones to be extremely fragile and to 
fracture easily. He and his colleagues are working to discover 
how to treat the disease by correcting the genetic defect in the 
patient’s own cells. 
 “We’re looking for ways to identify the progenitor stem cells 
that exist in the body, remove them, engineer them, and put 
them back in so they’ll function normally,” says Rowe. 
 An offshoot of this research deals with treating traumatic 
injuries, especially those sustained by members of the armed 
forces serving in war zones. The team has funding from the 
Department of Defense to develop strategies for salvaging limbs 
that would otherwise have to be amputated. The DOD is a 
major supporter of such research nationwide. 
x
 “This is a huge area,” says Rowe. “Because of the war and the 
horrific injuries that in the past would have killed soldiers, there 
is enormous interest in coming up with strategies to try to salvage 
bone that has sustained such devastating injuries.” 
 
A Multidisciplinary Approach
Rowe points out that the Health Center has been a leader in connective tissue research for nearly 40 years, having recruited people with expertise in this field when the Schools 
of Medicine and Dental Medicine were founded. 
 “The Health Center – and UConn in general – has been a 
powerhouse nationally and internationally in this area,” he says. 
 With such a high concentration of expertise available within the 
institution, Rowe and his colleagues in the Center for Regenerative 
Medicine and Skeletal Development have made it a point to 
cultivate a multidisciplinary approach. They work with tissue 
engineering specialists led by Cato T. Laurencin, M.D., Ph.D., 
dean of the School of Medicine, and collaborate with the New 
England Musculoskeletal Institute’s Department of Orthopaedic 
Surgery, directed by Jay R. Lieberman, M.D. They also work 
with experts at the University’s Storrs campus, including tissue 
engineers and specialists in materials science and computer 
science. “We see ourselves as having a central, coordinating role,” 
Rowe says. “We’ve built the infrastructure and can do the testing 
and evaluation of various ideas.” 
 
The Next Breakthrough 
Rowe sees his research on stem cells and regeneration as the next major step in the centuries-old evolution of medicine. Milestones in that evolution have included Hippocrates’ 
discovery of anatomy; understanding of infectious disease and 
immunization; innovations in anesthesia and sterile technique, which 
gave rise to modern surgery; development of antibiotics and the 
pharmaceutical industry; and breakthroughs in molecular biology  
and genetics, which brought about new diagnostic tools and drugs. 
 The next major breakthrough, Rowe predicts, will be cell-
based therapy, not only for use in bone regeneration, but also in 
neuroscience, endocrinology, and other fields. 
 “The breakthrough would be to take a patient’s own cells, put 
them through a process to engineer them to be any cell in the  
body you want them to be, and put them back into the body 
and have them be a match,” Rowe says. “It’s the ultimate in 
personalized, cell-based therapy. This is where medicine has to  
go, and we’re at the dawn of that revolution.” n
“It’s a very difficult challenge,” Rowe 
says. “A lot of work needs to be done 
before this becomes a reality. But we 
have the people, the tools, the resources, 
and the commitment to move the 
research forward.”
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A Scholarship Student Becomes a 
Scholar, Then a Scholarship Donor
Jack Rowe, M.D., has had many titles in his life: professor at Harvard and Columbia, CEO and chairman of Aetna, CEO of Mount Sinai 
Medical Center and School of Medicine in New 
York City, chair of the board of the University of 
Connecticut, and one last title that actually came first: 
scholarship student.  
 “I only had the benefit of higher education because I had full 
academic scholarships to college,” he says. “My family otherwise 
would not have been able to send me to school.” 
 College, then, made just about everything else in his 
life possible. From Canisius College in Buffalo, N.Y., to the 
University of Rochester School of Medicine and Dentistry, to 
Harvard Medical School and numerous high-profile positions, 
Rowe has had a lifelong involvement with education. 
 He and his wife, Valerie Rowe, Ph.D., a former professor at 
Fordham University, recently took their commitment one step 
further with a $2 million pledge through the UConn Foundation 
Gifts
White Coat Gala Benefits  
Clinician-Scientists 
Clinician-scientists at the Health Center are at the forefront of medicine, integrating clinical care, research, and basic science to bring discoveries from the bench to the 
bedside. This past spring, nearly 500 people attended the 
inaugural White Coat Gala, raising more than $450,000 to 
benefit clinician-scientists across the Health Center.  
 The honoree of the evening was Board of Trustees 
Distinguished Professor of Medicine Lawrence G. Raisz, M.D. 
Raisz has earned international prominence and numerous 
prestigious awards for his groundbreaking work in the 
management of osteoporosis and metabolic bone disease. At 
the Health Center, he headed the Division of Endocrinology 
and Metabolism until 1997 and served as the first program 
director of the Lowell P. Weicker, Jr. General Clinical Research 
Center. He has been the director of the UConn Center for 
Osteoporosis since its inception in 1990 and is associate 
director of the New England Musculoskeletal Institute.  
 Title sponsorship for the gala was generously provided by 
Aetna and Carole and Ray Neag, longtime supporters of the 
Health Center and the University. n
to the UConn Honors Program. The gift will provide 
much-needed support to the existing John and Valerie 
Rowe Health Professions Scholars Program, which 
encourages academically gifted students from 
underrepresented groups and low-income families 
to enter the health professions. The program is 
administered by the University’s Honors Program in 
partnership with the UConn Health Center.  
 “For me and my wife, our particular interest was in 
trying to give disadvantaged students who are academically 
talented the opportunity to reach their full potential,” 
he says. “The health professions are desperately in need of 
more talented minority physicians and nurses and dentists 
and lab technicians, and that’s been a consistent observation 
throughout my career. That’s why we did this.” 
 “Rowe Scholars have been admitted to medical, dental, 
and nursing schools, worked on honors theses, and served as 
campus leaders,” says Lynne Goodstein, director of the Honors 
Program. “The Rowes’ gift is a statement of their confidence in 
the Honors Program to provide life-changing opportunities to 
deserving students.” n
Nearly 500 people attended the University of Connecticut Health Center’s 
inaugural White Coat Gala. The event raised more than $450,000 for Health 
Center clinician-scientists.
Jack Rowe, M.D.
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Christopher Hughes, M.D., second-year UConn general surgery resident, has been named the Paul Farmer  Global Surgery Research Fellow at the Children’s  
Hospital in Boston. 
 Hughes, who has participated in several international 
surgical and medical trips to Belize, Bolivia, Honduras, India, 
and Ecuador, will spend the next two years researching and 
performing surgical care in Haiti and Africa. 
 “We’re kind of at the convergence of a lot of different forces 
involving international surgery at this point,” explains Hughes. 
“The documented need for surgery in resource-poor settings 
around the world is escalating, and people are actually looking 
into ways of capturing what those needs are for poor people and 
poor countries around the world.” 
 In the future, Hughes believes more surgical 
epidemiologists will look for surgery to fit in a broader context 
of the overall health care system. “The success of medical 
missions is often judged by how many surgeries the doctors 
performed,” explains Hughes. “But when we leave and 
dump the patients’ complications and follow-up care on the 
community doctor who is already overwhelmed, does that 
benefit the community as a whole?” n
Christopher Hughes Awarded  
Prestigious Paul Farmer Global  
Surgery Research Fellowship 
Christopher Hughes, M.D. (far left), pictured with other members of his surgical team 
working at a Bolivian hospital last year.
Drs. Anne Kenny and Anna Dongari-
Bagtzoglou Accepted to Prestigious 
Leadership Program
The Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) 
Program for Women at Drexel 
University College of Medicine has 
been an important and prestigious 
source of leadership training for 
women nationally and at the  
Health Center.   
 Recently accepted into the next 
class of this highly competitive 
program are Anne Kenny, M.D., 
associate professor in the Department  
of Medicine and the Center on Aging, 
and Anna Dongari-Bagtzoglou, 
D.D.S., M.S., Ph.D., associate 
professor in the Department of Oral 
Health Sciences and chair of the 
School of Dental Medicine’s Division 
of Periodontology.  
 Kenny is widely published; her 
clinical interests include interventions 
that decrease risk for falls, fractures, 
and frailty in older men and women, 
such as testosterone and vitamin D 
supplementation. In recent years, she 
has played a pivotal role in the development of the master’s degree 
in clinical and translational research. Dongari-Bagtzoglou was 
recently appointed to the National Advisory Dental and Craniofacial 
Research Council. Her research interests include the pathogenesis 
of oral opportunistic infections in the immunocompromised host 
and oral infection-induced inflammation. n
Anne Kenny, M.D.
Anna Dongari-Bagtzoglou, D.D.S., M.S., Ph.D.
$101,908,000 received  
for biomedical research at the UConn  
Health Center last fiscal year. 
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Within days of the earthquake that devastated Haiti, Robert Fuller, M.D., 
head of emergency medicine, was among the 
first physicians to arrive with the International 
Medical Corps to treat nearly 1,500 people for 
wounds, crush injuries, trauma, and shock. 
Fuller’s work in Port-au-Prince was recognized 
with a 2010 Health Care Hero Award from the 
Connecticut Hospital Association.
Health Care Hero in Haiti
